Kolexia
Drouillard Antoine
Gastro-entérologie
CHU Dijon-Bourgogne
Dijon, France
70 Activités
13 Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Tumeurs colorectales Adénocarcinome Tumeurs de l'oesophage Tumeurs du pancréas Carcinome épidermoïde Complications postopératoires Tumeurs du côlon Carcinomes Adénomes

Industries

Pierre Fabre
8 collaboration(s)
Dernière en 2023
Amgen
6 collaboration(s)
Dernière en 2023
AstraZeneca
4 collaboration(s)
Dernière en 2023
CONGRES COLLOQUES CONVENTIONS
2 collaboration(s)
Dernière en 2021

Dernières activités

Triplet chemotherapy with or without bevacizumab as first line treatment for metastatic colorectal cancer: An AGEO multicenter real-world study.
Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver   24 février 2024
VOCANGIO: Modifications in Retinal Microvascularization With OCT- Angiography in Patients With First-line Colorectal Cancer, Treated With Targeted Anti-angiogenic Therapy.
Essai Clinique (Centre Georges-François Leclerc)   12 février 2024
EXOMA2: A Multicenter, Prospective, Multi-organ Study to Evaluate the Clinical Benefit of an Exome "Complex" Analysis Versus an Exome "Simple" Analysis to Help the Therapeutic Decision for the Precision Medicine
Essai Clinique (Centre Georges-François Leclerc)   20 octobre 2023
Addition of trastuzumab to perioperative chemotherapy in HER2-positive gastroesophageal adenocarcinoma patients: A multicenter retrospective observational AGEO study.
Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver   03 juillet 2023
Performance of a blood-based RNA signature for gemcitabine-based treatment in metastatic pancreatic adenocarcinoma.
Journal of gastrointestinal oncology   10 avril 2023
Optimal treatment strategy after first-line induction therapy in advanced HER2-positive oeso-gastric adenocarcinoma-a retrospective, international, multicentric AGEO study.
Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association   07 mars 2023
TEDOPAM: A Randomized Non-comparative Phase II Study of Maintenance Therapy With OSE2101 Plus FOLFIRI, or FOLFIRI After Induction Therapy With FOLFIRINOX in Patients With Locally Advanced or Metastatic Pancreatic Ductal Adenocarcinoma (TEDOPaM-D17-01 PRODIGE 63 Study)
Essai Clinique (Ose Immunotherapeutics)   24 février 2023
Glycemic control in people with diabetes treated with cancer chemotherapy: contribution of continuous glucose monitoring.
Acta diabetologica   13 janvier 2023
Chemotherapy in advanced pancreatic adenosquamous carcinoma: A retrospective multicenter AGEO study.
International journal of cancer   03 janvier 2023
AMPULLOMA: Study of Survival and Description of Care for Patients With Degenerate Vaterian Ampulloma
Essai Clinique (Fédération Francophone de Cancérologie Digestive)   23 mars 2022